危地马拉
TO THE ORDER OF=LOTUS PHARMA , SA. 14 AVENIDA 16-71 BODEGA A10 ZONE 4, MIXCO GUATEMALA GAUTEMALA
会员限时活动
1580
元/年
企业联系人
详细交易记录
实时最新数据
交易概况
总交易额
485,297.20
交易次数
22
平均单价
22,058.96
最近交易
2025/07/17
TO THE ORDER OF=LOTUS PHARMA , SA. 14 AVENIDA 16-71 BODEGA A10 ZONE 4, MIXCO GUATEMALA GAUTEMALA 贸易洞察 (采购商)
过去5年,TO THE ORDER OF=LOTUS PHARMA , SA. 14 AVENIDA 16-71 BODEGA A10 ZONE 4, MIXCO GUATEMALA GAUTEMALA在危地马拉市场展现出 交易非常活跃,今年已有多笔成交。 总交易额达 485,297.20 ,累计 22 笔交易。 平均单价 22,058.96 ,最近一次交易于 2025/07/17。
贸易记录
日期 | 交易公司 | 交易描述 | 数量 | 金额 |
---|---|---|---|---|
2025-07-16 | REMUS PHARMACEUTICALS LIMITED | NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION : VANCOMYCIN HYDROCHLORIDE FOR INJECTION 500 MG | 28000.00VLS | 18200.00USD |
2025-07-16 | REMUS PHARMACEUTICALS LIMITED | NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION : VANCOMYCIN HYDROCHLORIDE FOR INJECTION 500 MG | 28080.00VLS | 18252.00USD |
2025-07-17 | REMUS PHARMACEUTICALS LIMITED | NON-HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION ;SITAGLIPTIN TABLETS USP 100MG B. NO: 000225F01 | 10071.00NOS | 35449.92USD |
2025-07-16 | REMUS PHARMACEUTICALS LIMITED | NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION : VANCOMYCIN HYDROCHLORIDE FOR INJECTION 500 MG | 28000.00VLS | 18200.00USD |
2025-07-17 | REMUS PHARMACEUTICALS LIMITED | NON-HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION ;LANSOPRAZOLEDELAYED-RELEASE CAPSULES USP 30MG | 10170.00NOS | 17797.50USD |
2025-07-16 | REMUS PHARMACEUTICALS LIMITED | NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION : VANCOMYCIN HYDROCHLORIDE FOR INJECTION 500 MG | 26880.00VLS | 17472.00USD |
贸易国家分析
HS编码情报
HS编码 | 产品描述 | 频次 |
---|---|---|
854140 | 光电二极管、晶体管、类似半导体器件 | 42 |
847130 | 便携式数字处理设备 | 35 |
851762 | 无线网络接入设备 | 28 |
847330 | 电子计算机零件 | 22 |
852910 | 天线和天线反射器 | 18 |
853400 | 印刷电路板 | 15 |